Position in NBIX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,121,634
-$68,887 QoQ
Shares Held
8,514
+1.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,509 | $747,034 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,121,634 | 8,514 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,190,521 | 8,394 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,088,085 | 7,751 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,015,952 | 8,083 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $967,197 | 8,745 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,301,118 | 9,532 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,389,432 | 20,738 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,508,587 | 10,958 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,631,455 | 11,829 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,508,124 | 11,446 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,311,525 | 11,658 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,132,825 | 12,013 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,259,379 | 12,442 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $1,831,134 | 15,331 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,571,483 | 14,796 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,390,259 | 14,262 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,809,000 | 19,296 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,069,801 | 24,302 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,781,390 | 29,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,680,971 | 27,548 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,138,430 | 21,989 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,542,801 | 16,096 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,600,006 | 16,639 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,993,114 | 16,337 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,242,771 | 14,359 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||